• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化涉及的分子机制。

Molecular mechanisms involved in atherosclerosis.

作者信息

Soufi Muhidien, Sattler Alexander M, Maisch Bernhard, Schaefer Jürgen R

机构信息

Department of Internal Medicine, Philipps-University Marburg, Germany.

出版信息

Herz. 2002 Nov;27(7):637-48. doi: 10.1007/s00059-002-2431-2.

DOI:10.1007/s00059-002-2431-2
PMID:12439635
Abstract

BACKGROUND

Research in atherosclerosis is a good example how helpful different disciplines such as clinicians, epidemiologists and basic science can collaborate. In recent years our knowledge on cellular and subcellular mechanisms involved in initiation and progress of atherosclerosis has expanded due to the shared knowledge of different disciplines and thanks to new technologies in molecular biology.

PATHOPHYSIOLOGY OF LDL AND HDL METABOLISM

The understanding of the molecular basis of inborn errors of LDL metabolism - such as familial hypercholesterolemia due to a defect of the LDL receptor - provided us new insights in physiology and pathophysiology of LDL metabolism. Most recently we have learned much about the vasoprotective HDL cholesterol. HDL is the major player in reverse cholesterol transport and some of its receptors such as ABCA1 and SR-BI were identified. This knowledge gives us a deeper understanding of the complex system which performs reverse cholesterol transport from peripheral tissue and the vessel wall back to the liver.

PLAQUE FORMATION

Furthermore the process of formation and progression of the atherosclerotic plaque has been the focus of recent research. The stability or instability of plaques is depending on the complex interaction of adhesion molecules, monocytes, macrophages, endothelial cells, cytokines, transmitters and proteinases. Since we are unable to prevent plaque formation completely, the stabilization of plaques is a major goal for the coming years. Despite some success (such as the use of statines and ACE inhibitors) there is still a long way to go.

摘要

背景

动脉粥样硬化的研究是一个很好的例子,展示了临床医生、流行病学家和基础科学等不同学科如何进行有益的合作。近年来,由于不同学科的知识共享以及分子生物学新技术的出现,我们对动脉粥样硬化发生和发展过程中涉及的细胞和亚细胞机制的认识有所扩展。

低密度脂蛋白(LDL)和高密度脂蛋白(HDL)代谢的病理生理学:对LDL代谢先天性缺陷的分子基础的理解——例如由于LDL受体缺陷导致的家族性高胆固醇血症——为我们提供了关于LDL代谢生理和病理生理的新见解。最近,我们对具有血管保护作用的HDL胆固醇有了更多了解。HDL是逆向胆固醇转运的主要参与者,并且已鉴定出其一些受体,如ABCA1和SR-BI。这些知识使我们对从外周组织和血管壁将胆固醇逆向转运回肝脏的复杂系统有了更深入的理解。

斑块形成

此外,动脉粥样硬化斑块的形成和进展过程一直是近期研究的重点。斑块的稳定性或不稳定性取决于黏附分子、单核细胞、巨噬细胞、内皮细胞、细胞因子、递质和蛋白酶之间的复杂相互作用。由于我们无法完全预防斑块形成,因此斑块的稳定化是未来几年的主要目标。尽管取得了一些成功(如使用他汀类药物和血管紧张素转换酶抑制剂),但仍有很长的路要走。

相似文献

1
Molecular mechanisms involved in atherosclerosis.动脉粥样硬化涉及的分子机制。
Herz. 2002 Nov;27(7):637-48. doi: 10.1007/s00059-002-2431-2.
2
HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.分子明确的家族性高胆固醇血症患者的高密度脂蛋白胆固醇水平
Ann Clin Lab Sci. 2002 Winter;32(1):50-4.
3
Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.载脂蛋白E在肝脏中的表达可抑制动脉粥样硬化的进展,而不会降低低密度脂蛋白受体缺陷小鼠的胆固醇水平。
Mol Ther. 2000 Feb;1(2):189-94. doi: 10.1006/mthe.2000.0028.
4
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.丹麦家族性高胆固醇血症的分子遗传基础与诊断
Dan Med Bull. 2002 Nov;49(4):318-45.
5
Lipoproteins and the pathogenesis of atherosclerosis.脂蛋白与动脉粥样硬化的发病机制
Circulation. 1987 Sep;76(3):508-14. doi: 10.1161/01.cir.76.3.508.
6
[Atherosclerosis--the molecular background].[动脉粥样硬化——分子背景]
Lakartidningen. 1991 Jan 16;88(3):127-9.
7
Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.在家族性高胆固醇血症小鼠模型中,由辅助依赖型腺病毒基因转移介导的人载脂蛋白A-I的长期稳定表达可抑制动脉粥样硬化进展并重塑动脉粥样硬化斑块。
Circulation. 2003 Jun 3;107(21):2726-32. doi: 10.1161/01.CIR.0000066913.69844.B2. Epub 2003 May 12.
8
[Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency), and coronary heart disease].胆固醇转运与胆固醇逆向转运障碍(家族性高胆固醇血症和胆固醇酯转运蛋白缺乏症)的分子遗传学以及冠心病
Rinsho Byori. 1995 Apr;43(4):342-6.
9
[Regulation of cholesterol metabolism and the development of atherosclerosis].[胆固醇代谢的调节与动脉粥样硬化的发展]
Vutr Boles. 1987;26(5):16-23.
10
Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.一名患有杂合子家族性高胆固醇血症和III型高脂蛋白血症的年轻患者出现的罕见黄瘤。
Am J Med Genet. 1996 Oct 16;65(2):149-54. doi: 10.1002/(SICI)1096-8628(19961016)65:2<149::AID-AJMG14>3.0.CO;2-Q.

引用本文的文献

1
Development of Biocompatible 3D-Printed Artificial Blood Vessels through Multidimensional Approaches.通过多维方法开发生物相容性3D打印人工血管
J Funct Biomater. 2023 Oct 8;14(10):497. doi: 10.3390/jfb14100497.
2
Concept of atherosclerosis velocity: is it a better measure of cardiovascular risk?动脉粥样硬化速度的概念:它是心血管风险的更好衡量指标吗?
Iran J Med Sci. 2013 Sep;38(3):210-20.
3
Quest for new biomarkers in atherosclerosis.动脉粥样硬化新生物标志物的探索
Mo Med. 2013 Jul-Aug;110(4):325-30.
4
The cholesterol emboli syndrome in atherosclerosis.动脉粥样硬化中的胆固醇栓子综合征。
Curr Atheroscler Rep. 2013 Apr;15(4):315. doi: 10.1007/s11883-013-0315-y.
5
TNF-α-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes.TNF-α 介导体血管平滑肌细胞的增殖涉及 Raf-1 介导的 Rb 失活和 E2F1 调控基因的转录。
Cell Cycle. 2012 Jan 1;11(1):109-18. doi: 10.4161/cc.11.1.18473.
6
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits.氟伐他汀和氯沙坦联合减轻兔动脉粥样硬化斑块中的动脉粥样硬化和巨噬细胞浸润。
Acta Pharmacol Sin. 2011 Oct;32(10):1259-65. doi: 10.1038/aps.2011.95. Epub 2011 Sep 12.
7
LDL receptor expression on T lymphocytes in old patients with Down syndrome.老年唐氏综合征患者T淋巴细胞上低密度脂蛋白受体的表达
Immun Ageing. 2005 Feb 10;2(1):3. doi: 10.1186/1742-4933-2-3.